Evidence map›Paper›PMID 23706308›Full record

ArticleVirology2013

HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition.

Nicholas A Wallace, Stephen L Gasior, Zachary J Faber, Heather L Howie, Prescott L Deininger, Denise A Galloway

Abstract read
In one paragraph

Article in Virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. HIV-1 Vpr and p21 restrict LINE-1 mobility.Nucleic acids research · 2018
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Nicholas A WallaceDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Stephen L Gasior
Zachary J Faber
Heather L Howie
Prescott L Deininger
Denise A Galloway
Fred Hutch Cancer Center · USTulane University · USUniversity of New Orleans · US

Funding

VIROLOGIC/GENETIC FACTORS OF HPV NEOPLASMSP01CA042792 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MADELEINE, MARGARET M · 1987 to 2011
$21.0M
UNCOVERING THE MECHANISMS OF OSTEOSARCOMA METASTASIS SUPPRESSION BY MTBPP20RR020152 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI DEININGER, PRESCOTT L. · 2004 to 2011
$17.0M
INTERACTIONS OF HPV ONCOGENES WITH THE P53 PATHWAYR01CA064795 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GALLOWAY, DENISE A. · 1995 to 2017
$8.6M
Mentoring a Cancer Genetics ProgramP20GM103518 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI DEININGER, PRESCOTT L. · 2012 to 2013
$4.3M
Sine RetrotranspositionR01GM045668 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI DEININGER, PRESCOTT L. · 1993 to 2014
$4.2M
CD22 Regulation of B Lymphocyte Function and SurvivalR01CA096547 · NCI · DUKE UNIVERSITY · PI TEDDER, THOMAS F · 2003 to 2007
$1.3M
NCI NIH HHS P01CA042702NCI NIH HHS P01 CA042792NCI NIH HHS R01 CA064795NCI NIH HHS R01 CA096547NCI NIH HHS T32CA0096547NCRR NIH HHS P20 RR020152NCRR NIH HHS P20RR020152NIGMS NIH HHS P20 GM103518NIGMS NIH HHS R01 GM045668NIGMS NIH HHS R01GM45668
6 · The paper itself

Abstract

The expression of the E6 protein from certain members of the HPV genus β (β HPV 5 and 8 E6) can disrupt p53 signaling by diminishing the steady state levels of two p53 modifying enzymes, ATR and p300. Here, we show that β-HPV 5 and 8 E6 are also capable of reducing the steady state levels of another p53 modifying enzyme, ATM, and as a result restrict LINE-1 retrotransposition. Furthermore, we show that the reduction of both ATM and LINE-1 retrotransposition is dependent upon the ability of β-HPV 8 E6 to bind and degrade p300. We use inhibitors and dominant negative mutants to confirm that ATM is needed for efficient LINE-1 retrotransposition. Furthermore, neither sensitivity to LINE-1 expression nor LINE-1 induced DSB formation is altered in an ATM deficient background. Together, these data illustrate the broad impact some β-HPVs have on DNA damage signaling by promoting p300 degradation.

Indexed as

Long Interspersed Nucleotide ElementsRecombination, GeneticAtaxia Telangiectasia Mutated ProteinsBetapapillomavirusCell Cycle ProteinsDNA-Binding ProteinsHeLa CellsHumansOncogene Proteins, Viralp300-CBP-Associated Factorp300-CBP Transcription FactorsProtein Serine-Threonine KinasesProteolysisTumor Suppressor ProteinsAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsOncogene Proteins, Viralp300-CBP-Associated Factorp300-CBP Transcription FactorsProtein Serine-Threonine KinasesTumor Suppressor Proteins

Identifiers

PMID23706308
PMCPMC3873879
OpenAlexW2045751302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.